Breaking News Instant updates and real-time market news.

CELG

Bought by BMY

$96.88

-0.6 (-0.62%)

13:04
08/29/19
08/29
13:04
08/29/19
13:04

Celgene granted orphan status for multiple myeloma treatment

The FDA granted Celgene orphan status for its treatment of multiple myeloma, or asymmetric immunoglobulin G1-based, B-cell maturation antigen x CD3 T-cell bispecific monoclonal antibody. Reference Link

  • 03

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

CELG Bought by BMY
$96.88

-0.6 (-0.62%)

08/26/19
PIPR
08/26/19
NO CHANGE
PIPR
Amgen price target raised to $218 from $210 at Piper Jaffray
Piper Jaffray analyst Christopher Raymond maintained an Overweight rating on Amgen (AMGN) and raised his price target on shares to $218 from $210 after Amgen announced it would acquire worldwide rights to Celgene's (CELG) Otelza for $13.4B in cash. Raymond said in a research note titled "Oh Otezla! Logical Deal Bolsters Commercial Footprint Meaningfully" that the deal "makes logical sense," and while "some may quibble with the price," the deal is highly accretive as it stands and adds "significant positive" net present value. The analyst concluded that the acquisition added around $8 per share to his sum of parts analysis of Amgen.
08/27/19
RBCM
08/27/19
NO CHANGE
Target $206
RBCM
Sector Perform
Amgen price target raised to $206 from $192 at RBC Capital
RBC Capital analyst Kennen MacKay raised his price target on Amgen to $206, saying that despite the "sticker shock" of its $13.4B deal for the Otezla franchise, the transaction is expected to be immediately accretive to earnings and fitting well with its existing inflammation and immunology portfolio. The analyst believes that Amgen should be able to grow revenue "majorly" over the next 3 years as it leverages Otezla potential with its legal victory on Enbrel, stating that there is a case for its multiple to re-rate higher. MacKay keeps his Sector Perform rating on Amgen shares as he awaits for its emerging pipeline to also "fill the shoes" of its maturing assets.
08/27/19
WELS
08/27/19
NO CHANGE
Target $220
WELS
Market Perform
Amgen price target raised to $220 from $202 at Wells Fargo
Wells Fargo analyst Jim Birchenough raised his price target for Amgen (AMGN) to $220 from $202 following the proposed acquisition of worldwide rights to OTEZLA from Celgene (CELG). While the proposed acquisition would be immediately accretive in 2020, he believes current valuation fairly contemplates future growth and that long-term value from OTEZLA should be considered in the context of potential earlier challenges to its intellectual property. The analyst reiterates a Market Perform rating on Amgen's shares.
08/27/19
OPCO
08/27/19
NO CHANGE
Target $240
OPCO
Outperform
Amgen price target raised to $240 from $230 at Oppenheimer
Oppenheimer analyst Jay Olson raised his price target for Amgen (AMGN) to $240 from $230 after the company announced plans to acquire Celgene's (CELG) Otezla for $13.4B or $11.2B net of tax benefits in an immediately accretive transaction that should close by the end of 2019 assuming certain conditions are met. The analyst is encouraged by the strategic rationale and potential operating leverage behind adding Otezla to a leading auto-immune portfolio bolstering the financial profile of Amgen that is already supported by recent new product launches and a burgeoning pipeline. Olson reiterates an Outperform rating on Amgen's shares.

TODAY'S FREE FLY STORIES

PG

Procter & Gamble

$126.65

0.54 (0.43%)

, UNP

Union Pacific

$181.23

-1.27 (-0.70%)

14:22
01/22/20
01/22
14:22
01/22/20
14:22
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$126.65

0.54 (0.43%)

UNP

Union Pacific

$181.23

-1.27 (-0.70%)

KMB

Kimberly-Clark

$145.50

0.91 (0.63%)

VFC

VF Corp.

$95.12

0.49 (0.52%)

LUV

Southwest

$53.64

0.1 (0.19%)

MTB

M&T Bank

$162.54

1.655 (1.03%)

KEY

KeyCorp

$19.61

0.11 (0.56%)

HBAN

Huntington Bancshares

$14.84

0.22 (1.51%)

AAL

American Airlines

$27.50

0.29 (1.07%)

JBLU

JetBlue

$19.90

0.81 (4.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 17

    Feb

  • 04

    Mar

TXN

Texas Instruments

$133.66

2.81 (2.15%)

, KMI

Kinder Morgan

$21.05

0.12 (0.57%)

14:22
01/22/20
01/22
14:22
01/22/20
14:22
Earnings
Notable companies reporting after market close »

Notable companies…

TXN

Texas Instruments

$133.66

2.81 (2.15%)

KMI

Kinder Morgan

$21.05

0.12 (0.57%)

CTXS

Citrix

$119.46

1.67 (1.42%)

TER

Teradyne

$73.17

1.64 (2.29%)

PTC

PTC

$79.86

0.93 (1.18%)

STLD

Steel Dynamics

$32.05

0.14 (0.44%)

SLM

Sallie Mae

$9.15

0.31 (3.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 29

    Jan

  • 12

    Feb

  • 26

    Feb

XOM

Exxon Mobil

$67.01

-0.58 (-0.86%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Periodicals
Exxon Mobil set to kick off U.K., Germany asset sales, Bloomberg says »

Exxon Mobil intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

CHEOY

Cochlear

$0.00

(0.00%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Downgrade
Cochlear rating change  »

Cochlear downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
01/22/20
01/22
14:16
01/22/20
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPG

Simon Property

$146.15

-2.96 (-1.99%)

14:15
01/22/20
01/22
14:15
01/22/20
14:15
Options
Simon Property put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

FCEL

FuelCell

$2.15

-0.725 (-25.26%)

, PKX

Posco

$51.39

-0.15 (-0.29%)

14:14
01/22/20
01/22
14:14
01/22/20
14:14
On The Fly
FuelCell plunges on bigger than expected loss, revenue miss »

Shares of FuelCell (FCEL)…

FCEL

FuelCell

$2.15

-0.725 (-25.26%)

PKX

Posco

$51.39

-0.15 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 31

    Jan

NK

NantKwest

$5.94

-0.32 (-5.11%)

14:14
01/22/20
01/22
14:14
01/22/20
14:14
Hot Stocks
Breaking Hot Stocks news story on NantKwest 

NantKwest trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NK

NantKwest

$5.90

-0.36 (-5.75%)

14:09
01/22/20
01/22
14:09
01/22/20
14:09
Hot Stocks
Breaking Hot Stocks news story on NantKwest »

NantKwest trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRP

Neurotrope

$2.73

1.3 (90.91%)

14:08
01/22/20
01/22
14:08
01/22/20
14:08
Syndicate
Neurotrope announces $18M registered direct offering »

Neurotrope announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$222.17

0.69 (0.31%)

, TWTR

Twitter

$34.34

0.25 (0.73%)

14:05
01/22/20
01/22
14:05
01/22/20
14:05
On The Fly
#SocialStocks: No ads in WhatsApp, No edit button for Twitter »

Welcome to…

FB

Facebook

$222.17

0.69 (0.31%)

TWTR

Twitter

$34.34

0.25 (0.73%)

SNAP

Snap

$19.25

0.24 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 29

    Jan

  • 04

    Feb

  • 06

    Feb

MPLX

MPLX

$25.13

-0.54 (-2.10%)

14:05
01/22/20
01/22
14:05
01/22/20
14:05
Options
MPLX call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BA

Boeing

$310.94

-2.37 (-0.76%)

14:04
01/22/20
01/22
14:04
01/22/20
14:04
Periodicals
Boeing CEO says 737 MAX return delayed due to simulator training, CNBC reports »

Boeing CEO Dave Calhoun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

CNCE

Concert Pharmaceuticals

$10.86

1.04 (10.59%)

14:04
01/22/20
01/22
14:04
01/22/20
14:04
Recommendations
Concert Pharmaceuticals analyst commentary  »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$311.75

-1.56 (-0.50%)

13:58
01/22/20
01/22
13:58
01/22/20
13:58
Periodicals
Boeing aims to resume 737 MAX production before return to service, CNBC says »

Dave Calhoun, the new CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

TEVA

Teva

$10.53

0.505 (5.04%)

13:55
01/22/20
01/22
13:55
01/22/20
13:55
Conference/Events
The Food and Drug Law Institute holds a webinar »

The FDLI summarizes the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 10

    Feb

  • 12

    Feb

  • 09

    Mar

CNCE

Concert Pharmaceuticals

$10.37

0.55 (5.60%)

13:53
01/22/20
01/22
13:53
01/22/20
13:53
Recommendations
Concert Pharmaceuticals analyst commentary  »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAF

GrafTech

$13.00

0.61 (4.92%)

13:45
01/22/20
01/22
13:45
01/22/20
13:45
Options
GrafTech call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

MSFT

Microsoft

$166.62

0.14 (0.08%)

13:38
01/22/20
01/22
13:38
01/22/20
13:38
Hot Stocks
Microsoft: Misconfiguration investigation found no malicious use of database »

Microsoft said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 25

    Feb

13:35
01/22/20
01/22
13:35
01/22/20
13:35
General news
Treasury Action: there's been no real inspiration in the markets today »

Treasury Action:…

MDP

Meredith

$30.49

-0.1 (-0.33%)

13:34
01/22/20
01/22
13:34
01/22/20
13:34
Hot Stocks
Meredith to partner with Ayesha Curry to launch new quarterly brand »

Meredith Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

BA

Boeing

$304.40

-8.91 (-2.84%)

13:31
01/22/20
01/22
13:31
01/22/20
13:31
Periodicals
Boeing CEO says 737 MAX output may restart in 'a few months,' Bloomberg reports »

Bloomberg cites comments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

VFF

Village Farms

$5.84

0.01 (0.17%)

13:30
01/22/20
01/22
13:30
01/22/20
13:30
Options
Buyer crosses wide spread for Village Farm upside calls »

Buyer crosses wide spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$33.66

-0.02 (-0.06%)

13:27
01/22/20
01/22
13:27
01/22/20
13:27
Periodicals
New York Times seen as potential suitor for 'Serial' podcast maker, WSJ says »

Serial Productions, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.